Stryker concluded 2025 with an outstanding fourth quarter, achieving $7.2 billion in net sales, an 11.4% increase, and adjusted EPS of $4.47, up 11.5%. The company also expanded its adjusted operating margin by 100 basis points to 30.2%, driven by healthy procedural volumes and strong demand for capital products.
Reported net sales increased 11.4% to $7.2 billion in Q4 2025.
Organic net sales grew by 11.0% in the fourth quarter.
Adjusted operating income margin expanded by 100 bps to 30.2%.
Adjusted EPS increased 11.5% to $4.47.
Stryker anticipates 2026 organic net sales growth to be between 8.0% and 9.5%, with adjusted net earnings per diluted share in the range of $14.90 to $15.10, driven by strong momentum from 2025, healthy procedural volumes, and robust demand for capital products.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance